Skip to content
Catalyst

PapersPMID:15498524

Dimethylglycine supplementation does not affect plasma homocysteine concentrations in pre-dialysis chronic renal failure patients.

Clinical biochemistry2004The record ↗

  1. Finding, very limited evidenceno difference foundPlasma total homocysteine (tHcy) concentration

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “No significant differences were observed in plasma homocysteine (P = 0.624), glycine betaine (P = 0.452) and methionine (P = 0.457) concentrations between dimethylglycine and placebo treatments.”
    Study
    crossover
    Duration
    4 weeks
    Dose studied
    400 mg dimethylglycine daily for 28 days
    Population
    pre-dialysis chronic renal failure patients

Study record

Design
crossover trial
Species
human
Population
pre-dialysis chronic renal failure patients
Participants
7
Comparator
placebo
Duration
28 days
Endpoints measured
3